EARLY Labs is a Bio-Tech company, operating in the field of Volatile Organic Compound based diagnostics. The company is developing a revolutionary multi-cancer test platform, currently focusing on lung cancer, detecting lung cancer in urine samples, from it's earliest stages – with groundbreaking 90% stage I sensitivity and specificity results. By Q4 2024 the platform will be calibrated to run Colon testing as well, and other cancer types to follow. Simplicity of the test, which can be done at home or at pharmacies, using a urine collection kit, is expected to break existing uptake barriers such as invasiveness, radiation, long waiting lists, inconvenience and more, and completely change the cancer screening paradigm.
Cumulative Funding Raised Over Time ($)
Employees Over Time
EARLY Labs Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Mar 12, 2023
www.dailymail.co.uk
Scientists plan UK clinical trial of rats trained to sniff out cancer
#Customers
Feb 16, 2023
www.jewishnews.co.uk
Israeli scientists training rats to sniff out lung cancer now want UK trial
#Expand
Feb 15, 2023
www.timesofisrael.com
Lab claims it teaches rats to detect lung cancer with 93% accuracy by sniffing urine
#Investment #Customers
Jan 29, 2023
www.mako.co.il
N12 - פיתוח ישראלי: חולדות יוכלו לזהות סרטן ריאות בשלב מוקדם